Related Experiment Video
Updated: Jun 25, 2026
Experimental Manipulation of Body Size to Estimate Morphological Scaling Relationships in Drosophila
Published on: October 1, 2011
Mechanistic basis of using body size and maturation to predict clearance in humans
Brian J Anderson1, Nick H G Holford
1Department of Anaesthesiology, University of Auckland School of Medicine, New Zealand.
Insights
Understanding how children process drugs is crucial. This study uses advanced models to explain how body size and maturation affect drug clearance, improving pediatric dosing predictions.
Area of Science:
- Pharmacokinetics
- Pediatric Pharmacology
- Biomedical Modeling
Background:
- Pediatric drug clearance differs significantly from adults due to growth and maturation.
- Accurate pharmacokinetic models are essential for safe and effective pediatric dosing.
- Current models often require refinement to account for body composition and developmental changes.
Purpose of the Study:
- To develop and apply mechanistic models for predicting drug clearance in children.
- To investigate the influence of size, maturation, and organ function on pediatric pharmacokinetics.
- To improve dosing predictions for pediatric populations and aid in drug development.
Main Methods:
- Utilized allometric scaling with an exponent of 3/4 for size-based adjustments.
- Employed the sigmoid hyperbolic model to describe maturation processes, including asymmetry.
- Analyzed pooled data for creatinine, glomerular filtration rate (GFR), morphine, and paracetamol clearance.
Main Results:
- Allometric scaling proved superior to body surface area scaling for pediatric pharmacokinetic parameters.
- The sigmoid hyperbolic model effectively described maturation, with an added asymmetry parameter.
- Glomerular filtration rate (GFR) maturation precedes paracetamol or morphine clearance, indicating a sequential maturation of elimination pathways.
Conclusions:
- Mechanistic pharmacokinetic modeling enhances understanding of drug disposition in children.
- Improved dosing predictions are achievable through models that incorporate size and maturation.
- These approaches support safer drug development and therapeutic strategies for pediatric patients.
Abstract:
Growth and development are two major aspects of children not readily apparent in adults. Clearance in the paediatric population should be investigated using models that describe size, maturation and organ function influences. Size is the primary covariate and although lean body weight is argued as a better measure than total body weight, the use of different fractions of fat mass to explain how pharmacokinetic parameters vary with body composition has been proposed. Allometric scaling using an empiric power exponent of 3/4 is superior to scaling using body surface area. The sigmoid hyperbolic model has proven useful to describe maturation. An extra parameter that describes asymmetry can be incorporated into this model. These descriptors are used to illustrate creatinine, morphine and paracetamol clearance in children. Simultaneous investigation of pooled GFR, paracetamol and morphine data enabled testing for shared common features of maturation processes. Results suggest that GFR matures before paracetamol or morphine clearance, consistent with phase II conjugation processes that convert xenobiotics to water soluble forms that can subsequently be eliminated from the body through the renal system. The use of such mechanistic approaches improves understanding of paediatric pharmacokinetics; improving dosing predictions and allowing projection in exploratory drug development.
Related Concept Videos
01:17Clearance Models: Noncompartmental Models
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
01:09Clearance Models: Physiological Models
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's proficiency in drug...
00:56One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
01:25Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion